236 related articles for article (PubMed ID: 11392031)
1. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
de Lignieres B
J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
[TBL] [Abstract][Full Text] [Related]
2. Oral micronized progesterone.
de Lignières B
Clin Ther; 1999 Jan; 21(1):41-60; discussion 1-2. PubMed ID: 10090424
[TBL] [Abstract][Full Text] [Related]
3. Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT.
Gibbons WE; Thorneycroft IH
J Reprod Med; 1999 Feb; 44(2 Suppl):203-8. PubMed ID: 11392033
[TBL] [Abstract][Full Text] [Related]
4. Estrogen, progestogens and cardiovascular risk.
Stefanick ML
J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and endometrial cancer.
Emons G; Huschmand-Nia A; Krauss T; Hinney B
Onkologie; 2004 Apr; 27(2):207-10. PubMed ID: 15138357
[TBL] [Abstract][Full Text] [Related]
6. Oestrogens and endometrial hyperplasia.
Thom MH; Studd JW
Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
[TBL] [Abstract][Full Text] [Related]
7. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
[TBL] [Abstract][Full Text] [Related]
9. Balancing safety and efficacy focus on endometrial protection.
Boroditsky RS
J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
[TBL] [Abstract][Full Text] [Related]
10. Vaginal bleeding patterns in women receiving hormone replacement therapy. Impact of various progestogen regimens.
Thorneycroft IH; Gibbons WE
J Reprod Med; 1999 Feb; 44(2 Suppl):209-14. PubMed ID: 11392034
[TBL] [Abstract][Full Text] [Related]
11. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
Magnusson C; Weiderpass E
Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone replacement therapy: endometrial and breast effects.
Yeh IT
Adv Anat Pathol; 2007 Jan; 14(1):17-24. PubMed ID: 17198307
[TBL] [Abstract][Full Text] [Related]
13. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
14. Androgenic progestins amplify the breast cancer risk associated with hormone replacement therapy by boosting IGF-I activity.
McCarty MF
Med Hypotheses; 2001 Feb; 56(2):213-6. PubMed ID: 11425289
[TBL] [Abstract][Full Text] [Related]
15. Rationale for hormone replacement therapy in atherosclerosis prevention.
Wagner JD
J Reprod Med; 2000 Mar; 45(3 Suppl):245-58. PubMed ID: 10756506
[TBL] [Abstract][Full Text] [Related]
16. [Estrogen and progestin treatment in postmenopause. Effects on the endometrium].
Grio R; Curti A; Gobbi F; Piacentino R
Minerva Ginecol; 1998 Dec; 50(12):553-6. PubMed ID: 10069171
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and risk of breast cancer: the role of progestins.
Stahlberg C; Pedersen AT; Lynge E; Ottesen B
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
[TBL] [Abstract][Full Text] [Related]
18. Reversal by medical treatment of endometrial hyperplasia caused by estrogen replacement therapy.
Figueroa-Casas PR; Ettinger B; Delgado E; Javkin A; Vieder C
Menopause; 2001; 8(6):420-3. PubMed ID: 11723414
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
[TBL] [Abstract][Full Text] [Related]
20. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]